Literature DB >> 25919728

Neonatal sepsis 2004-2013: the rise and fall of coagulase-negative staphylococci.

Matthew J Bizzarro1, Veronika Shabanova2, Robert S Baltimore3, Louise-Marie Dembry4, Richard A Ehrenkranz5, Patrick G Gallagher5.   

Abstract

OBJECTIVES: To evaluate data for the period 2004-2013 to identify changes in demographics, pathogens, and outcomes in a single, level IV neonatal intensive care unit. STUDY
DESIGN: Sepsis episodes were identified prospectively and additional information obtained retrospectively from infants with sepsis while in the neonatal intensive care unit from 2004 to 2013. Demographics, hospital course, and outcome data were collected and analyzed. Sepsis was categorized as early (≤3 days of life) or late-onset (>3 days of life).
RESULTS: Four hundred fifty-two organisms were identified from 410 episodes of sepsis in 340 infants. Ninety percent of cases were late-onset. Rates of early-onset sepsis remained relatively static throughout the study period (0.9 per 1000 live births). For the first time in decades, most (60%) infants with early-onset sepsis were very low birth weight and Escherichia coli (45%) replaced group B streptococcus (36%) as the most common organism associated with early-onset sepsis. Rates of late-onset sepsis, particularly due to coagulase-negative staphylococci, decreased significantly after implementation of several infection-prevention initiatives. Coagulase-negative staphylococci were responsible for 31% of all cases from 2004 to 2009 but accounted for no cases of late-onset sepsis after 2011.
CONCLUSIONS: The epidemiology and microbiology of early- and late-onset sepsis continue to change, impacted by targeted infection prevention efforts. We believe the decrease in sepsis indicates that these interventions have been successful, but additional surveillance and strategies based on evolving trends are necessary.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25919728      PMCID: PMC4413005          DOI: 10.1016/j.jpeds.2015.02.009

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  23 in total

1.  Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues.

Authors:  Barbara J Stoll; Nellie I Hansen; Pablo J Sánchez; Roger G Faix; Brenda B Poindexter; Krisa P Van Meurs; Matthew J Bizzarro; Ronald N Goldberg; Ivan D Frantz; Ellen C Hale; Seetha Shankaran; Kathleen Kennedy; Waldemar A Carlo; Kristi L Watterberg; Edward F Bell; Michele C Walsh; Kurt Schibler; Abbot R Laptook; Andi L Shane; Stephanie J Schrag; Abhik Das; Rosemary D Higgins
Journal:  Pediatrics       Date:  2011-04-25       Impact factor: 7.124

2.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

3.  Statewide NICU central-line-associated bloodstream infection rates decline after bundles and checklists.

Authors:  Joseph Schulman; Rachel Stricof; Timothy P Stevens; Michael Horgan; Kathleen Gase; Ian R Holzman; Robert I Koppel; Suhas Nafday; Kathleen Gibbs; Robert Angert; Aryeh Simmonds; Susan A Furdon; Lisa Saiman
Journal:  Pediatrics       Date:  2011-02-21       Impact factor: 7.124

4.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

5.  Seventy-five years of neonatal sepsis at Yale: 1928-2003.

Authors:  Matthew J Bizzarro; Craig Raskind; Robert S Baltimore; Patrick G Gallagher
Journal:  Pediatrics       Date:  2005-09       Impact factor: 7.124

6.  Early-onset neonatal sepsis in the era of group B streptococcal prevention.

Authors:  R S Baltimore; S M Huie; J I Meek; A Schuchat; K L O'Brien
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

7.  Is bloodstream infection preventable among premature infants? A tale of two cities.

Authors:  Hany Aly; Victor Herson; Anne Duncan; Jill Herr; Jean Bender; Kantilal Patel; Ayman A E El-Mohandes
Journal:  Pediatrics       Date:  2005-06       Impact factor: 7.124

8.  A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.

Authors:  J S Garland; C P Alex; C D Mueller; D Otten; C Shivpuri; M C Harris; M Naples; J Pellegrini; R K Buck; T L McAuliffe; D A Goldmann; D G Maki
Journal:  Pediatrics       Date:  2001-06       Impact factor: 7.124

9.  Distinguishing true coagulase-negative Staphylococcus infections from contaminants in the neonatal intensive care unit.

Authors:  C M Healy; C J Baker; D L Palazzi; J R Campbell; M S Edwards
Journal:  J Perinatol       Date:  2012-04-12       Impact factor: 2.521

10.  A quality improvement initiative to reduce central line-associated bloodstream infections in a neonatal intensive care unit.

Authors:  Matthew J Bizzarro; Barbara Sabo; Melanie Noonan; Mary-Pat Bonfiglio; Veronika Northrup; Karen Diefenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2010-03       Impact factor: 3.254

View more
  34 in total

1.  Overcoming Barriers and Identifying Opportunities for Developing Maternal Immunizations: Recommendations From the National Vaccine Advisory Committee.

Authors: 
Journal:  Public Health Rep       Date:  2017-04-05       Impact factor: 2.792

Review 2.  Challenges and opportunities for antibiotic stewardship among preterm infants.

Authors:  Sagori Mukhopadhyay; Shaon Sengupta; Karen M Puopolo
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2018-11-13       Impact factor: 5.747

3.  Vital signs analysis algorithm detects inflammatory response in premature infants with late onset sepsis and necrotizing enterocolitis.

Authors:  Leena B Mithal; Ram Yogev; Hannah L Palac; Daniel Kaminsky; Ilan Gur; Karen K Mestan
Journal:  Early Hum Dev       Date:  2018-01-23       Impact factor: 2.079

4.  Neonatal Sepsis Epidemiology in a Rural Province in Southeastern Cambodia, 2015-2017.

Authors:  Sarah M Labuda; Vantha Te; Chivorn Var; Navapol Iv Ek; Sosorphea Seang; Alessandra N Bazzano; Richard A Oberhelman
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

5.  Randomized Controlled Trial of Talactoferrin Oral Solution in Preterm Infants.

Authors:  Michael P Sherman; David H Adamkin; Victoria Niklas; Paula Radmacher; Jan Sherman; Fiona Wertheimer; Karel Petrak
Journal:  J Pediatr       Date:  2016-05-31       Impact factor: 4.406

Review 6.  Adverse consequences of neonatal antibiotic exposure.

Authors:  Charles M Cotten
Journal:  Curr Opin Pediatr       Date:  2016-04       Impact factor: 2.856

Review 7.  Defining neonatal sepsis.

Authors:  James L Wynn
Journal:  Curr Opin Pediatr       Date:  2016-04       Impact factor: 2.856

8.  Population-based study of early-onset neonatal sepsis in Canada.

Authors:  Michael Sgro; Anna Kobylianskii; Mark H Yudin; Dat Tran; Julia Diamandakos; Jonathan Sgro; Douglas M Campbell
Journal:  Paediatr Child Health       Date:  2018-04-24       Impact factor: 2.253

9.  Morbidity and mortality of coagulase-negative staphylococcal sepsis in very-low-birth-weight infants.

Authors:  Joseph B Cantey; Kelsey R Anderson; Ram R Kalagiri; Lea H Mallett
Journal:  World J Pediatr       Date:  2018-03-13       Impact factor: 2.764

10.  Antibiotic regimens for late-onset neonatal sepsis.

Authors:  Steven Kwasi Korang; Sanam Safi; Chiara Nava; Gorm Greisen; Munish Gupta; Ulrik Lausten-Thomsen; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.